ADVFN Logo
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Dare Bioscience Inc

Dare Bioscience Inc (DARE)

3.60
-0.04
(-1.10%)
Closed July 24 4:00PM
3.60
0.00
(0.00%)
After Hours: 4:00PM

Empower your portfolio: Real-time discussions and actionable trading ideas.

Key stats and details

Current Price
3.60
Bid
3.51
Ask
3.83
Volume
14,720
3.59 Day's Range 3.64
3.05 52 Week Range 9.576
Market Cap
Previous Close
3.64
Open
3.64
Last Trade
20
@
3.51
Last Trade Time
Financial Volume
$ 53,130
VWAP
3.6094
Average Volume (3m)
453,262
Shares Outstanding
8,424,408
Dividend Yield
-
PE Ratio
-1.01
Earnings Per Share (EPS)
-3.58
Revenue
2.81M
Net Profit
-30.16M

About Dare Bioscience Inc

Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve... Dare Bioscience Inc is a biopharmaceutical company committed to advancing innovative products for women's health. The company identifies, develops and brings to market a diverse portfolio of differentiated therapies that prioritize women's health and well-being, expand treatment options, and improve outcomes, primarily in the areas of contraception, fertility, and vaginal and sexual health. The company's first product, XACIATO is a single-dose vaginal gel prescription product for the treatment of bacterial vaginosis in females 12 years of age and older. The company's portfolio includes two product candidates in advanced clinical development namely, Ovaprene and Sildenafil Cream. Show more

Sector
Pharmaceutical Preparations
Industry
Pharmaceutical Preparations
Headquarters
Wilmington, Delaware, USA
Founded
1970
Dare Bioscience Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker DARE. The last closing price for Dare Bioscience was $3.64. Over the last year, Dare Bioscience shares have traded in a share price range of $ 3.05 to $ 9.576.

Dare Bioscience currently has 8,424,408 shares outstanding. The market capitalization of Dare Bioscience is $30.66 million. Dare Bioscience has a price to earnings ratio (PE ratio) of -1.01.

DARE Latest News

Daré Bioscience Regains Compliance with Nasdaq Minimum Bid Price Rule

SAN DIEGO, July 19, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health and wellbeing of women, announced that it was notified by the Nasdaq...

Daré Bioscience Announces Reverse Stock Split

Shares Expected to Begin Trading on Split-Adjusted Basis on July 1, 2024 SAN DIEGO, June 27, 2024 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in innovation for the health...

Daré Bioscience Announces Publication in Obstetrics & Gynecology of Phase 2b Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder

Phase 2b study demonstrated topical Sildenafil Cream, 3.6% improved outcomes among women with female sexual arousal disorder (FSAD), particularly in an exploratory subset of women with FSAD with...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.18015.266235854853.41993.8553.18538343.52056441CS
4-1.6788-31.80268242785.27885.643.053166204.18162451CS
12-0.24-6.253.847.563.054532624.81411012CS
26-0.12-3.225806451613.727.563.055335984.69067855CS
52-5.976-62.40601503769.5769.5763.054703254.84133022CS
156-14.16-79.729729729717.7630.123.05123422918.0681908CS
260-5.64-61.0389610399.2446.23.05149341019.64815833CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NUZENuZee Inc
$ 3.2954
(219.94%)
135.82M
DRMADermata Therapeutics Inc
$ 2.55
(96.15%)
65.31M
PIRSPieris Pharmaceuticals Inc
$ 14.9491
(87.33%)
5.85M
SLNASelina Hospitality PLC
$ 0.0456
(75.38%)
1.22B
QXOQXO Inc
$ 119.99
(51.31%)
218.2k
NXTTNext Technology Holding Inc
$ 2.50
(-57.04%)
965.73k
NUWENewellis Inc
$ 2.48
(-40.24%)
1.01M
LITMSnow Lake Resources Ltd
$ 0.625
(-35.43%)
5.76M
VWEVintage Wine Estates Inc
$ 0.0732
(-34.58%)
37.22M
CONNConns Inc
$ 0.345
(-31.95%)
4.45M
SLNASelina Hospitality PLC
$ 0.0456
(75.38%)
1.22B
NVDANVIDIA Corporation
$ 114.25
(-6.80%)
327.86M
SGMOSangamo Therapeutics Inc
$ 0.5584
(39.15%)
263.13M
SQQQProShares UltraPro Short QQQ
$ 9.06
(10.76%)
203.95M
TSLATesla Inc
$ 215.99
(-12.33%)
168.55M

DARE Discussion

View Posts
powerbattles powerbattles 2 months ago
$DARE took the starter! Secure $22 million in the non-dilutive & phase 2 and phase 3 coming $$$
👍️0
harry crumb harry crumb 3 months ago
Wouldn’t touch this turd with monopoly money until after the r/s, an after the shorting!
👍️0
Awl416 Awl416 3 months ago
Daré Bioscience Secures $22 Million in Non-Dilutive Strategic Royalty Financing to Advance Phase 3 First-in-Category Women’s Health Product Candidates through Key Catalysts
👍️0
willlbone willlbone 3 months ago
Vote on R/S.
👍️0
glenn1919 glenn1919 5 months ago
DARE.................................................https://stockcharts.com/h-sc/ui?s=DARE&p=W&b=5&g=0&id=p86431144783
👍️0
starkd748 starkd748 7 months ago
It's dead lol
👍️0
Monksdream Monksdream 8 months ago
DARE new 52 week low
👍️0
Monksdream Monksdream 10 months ago
DARE new 52 week low
👍️0
Monksdream Monksdream 10 months ago
DARE new 52 week low
👍️0
Monksdream Monksdream 12 months ago
DARE newb52 week low
👍️0
harry crumb harry crumb 1 year ago
Might be a runner in due time
👍️0
nonsequetor nonsequetor 1 year ago
The DARE train has not even left the station... gathering up steam...
👍️0
harry crumb harry crumb 1 year ago
1.00 average, 100k
👍️0
nonsequetor nonsequetor 1 year ago
I hope everyone loaded up Monday...
👍️0
nonsequetor nonsequetor 2 years ago
Monday, Jan 23, is the day...
👍️0
harry crumb harry crumb 2 years ago
Yep agree
👍️0
nonsequetor nonsequetor 2 years ago
If Ovaprene is approved by the FDA, it could be the first monthly non-hormonal contraceptive product for women and a first-in-category option for women seeking a hormone-free, self-administered and monthly birth control method.

https://www.biospace.com/article/releases/dare-bioscience-announces-ide-approval-for-a-single-arm-open-label-pivotal-contraceptive-efficacy-study-of-ovaprene-an-investigational-hormone-free-monthly-intravaginal-contraceptive/
👍️0
nonsequetor nonsequetor 2 years ago
DARE starts revenue soon with its first approved drug, Xaciato and its licensing partner OGN. Q1 or Q2. Milestone payments and double digit royalties.

Additionally, they have up to three products entering Ph3 trials this year: Ovaprene, Sildenafil and HRT-1. Ovaprene for sure is entering Ph3 this summer with NIH and licensing partner $BAYRY.

By 2024, they could have FDA-approved products and $4-$5B market share and exclusivity.
👍️0
nonsequetor nonsequetor 2 years ago
DARE Since Post:
$0.3266
(38.27%)
Then:$0.8534
Now:$1.18

Nice chunk of change so far...
👍️0
harry crumb harry crumb 2 years ago
Mayb, mayb not
👍️0
nonsequetor nonsequetor 2 years ago
Since my call
Jan 03, 2023 9:29 AM

$DARE It has begun...

DARE Since Post:
$0.2566
(30.07%)
Then:$0.8534
Now:$1.11

UM...AH... looks like a winner already...
and it has not even started!

BUT...

I really don't care what negativity others post. I have done my DD, bought low, and will ride the wave to prosperity.

DARE is the real thing, with one of a kind, first in class products, that will turn many heads and make some (who do their own DD) wealthy.

Good fortune to all (except shorts, who bet wrong on this leg up).
👍️0
harry crumb harry crumb 2 years ago
Could be but highly unlikely this becomes a winner
👍️0
nonsequetor nonsequetor 2 years ago
Just a little bit of DD will prove you wrong.
👍️0
harry crumb harry crumb 2 years ago
Dont count on it, this team is not an has not proven anything yet. Could use new management for a change, the stock does note promote a very good company
👍️0
nonsequetor nonsequetor 2 years ago
Hop aboard, this is just the beginning!
👍️0
nonsequetor nonsequetor 2 years ago
DARE up over 30% already this year.
👍️0
nonsequetor nonsequetor 2 years ago
Up 20% in 2 days
👍️0
nonsequetor nonsequetor 2 years ago
UP 10% since yesterday morning.
👍️0
harry crumb harry crumb 2 years ago
This pos needs to be shutdown, what a scam
👍️0
harry crumb harry crumb 2 years ago
Some more news on dare
👍️0
nonsequetor nonsequetor 2 years ago
Daré Bioscience Announces Subject Screening for Phase 2b RESPOND Study of Sildenafil Cream, 3.6% in Women with Female Sexual Arousal Disorder Complete

https://finance.yahoo.com/news/dar-bioscience-announces-subject-screening-120000980.html
👍️0
harry crumb harry crumb 2 years ago
Some news an this turd is stagnant, very boring company here
👍️0
harry crumb harry crumb 2 years ago
Looks like this pos is going to its 3 yr low of .75 area. What junk!
👍️0
nonsequetor nonsequetor 2 years ago
Q4 will be interesting
👍️0
nonsequetor nonsequetor 2 years ago
WOW!! Nice EOD catapult!!
👍️0
nonsequetor nonsequetor 2 years ago
Another week... another wait...

ZZZZZZZZZZZZZZZZZZZZZZ
👍️0
MattSav MattSav 2 years ago
Good looking week... Hope everyone is enjoying this move upwards... I know we are waiting on 4th quarter for real numbers but wondering if the sentiment here is good enough to through another 10k on shares lol
👍️0
nonsequetor nonsequetor 2 years ago
YES!
👍️0
MattSav MattSav 2 years ago
So should we be excited that they are doing Financials on a Tuesday?
👍️0
MattSav MattSav 2 years ago
So is the corporate presentation today or what I can't open the damn thing
👍️0
nonsequetor nonsequetor 2 years ago
https://www.sec.gov/Archives/edgar/data/0001401914/000149315222019342/ex3-1.htm
👍️0
MattSav MattSav 2 years ago
Anyone find out how the vote went?
👍️0
kruy kruy 2 years ago
You do realize that all the upfront payments and tiered royalties have to be split with the labs that actually invented and produce these products. DARE is only the middleman. These details are all spelled out in the last SEC annual filing.
The best thing that could happen for us shareholders is that some big company that needs a pipeline will buy out this company and its entire complicated business model. Give me $5 a share and I'm happy. Reality wise, I think we could only get $3-$4 because they would need to come to agreements with all the labs that actually engineered all of the products. Either way, I'd be happy with any buyout because the business model as is could take a long time for DARE to break even or show a profit after splitting royalties with all parties involved.
👍️0
nonsequetor nonsequetor 2 years ago
$$$$ Coming in from the Gates!
https://ih.advfn.com/stock-market/NASDAQ/dare-bioscience-DARE/stock-news/88547783/current-report-filing-8-k
👍️0
nonsequetor nonsequetor 2 years ago
This DARE stock will drive a sane man crazy!
👍️0
harry crumb harry crumb 2 years ago
Employee stock incentive plan goes into effect with dare Bod approval. Always good news to have a employee purchase plan for company stock
👍️0
MattSav MattSav 2 years ago
So im new to this stock... What are the opinions of the stock not getting its approval to increase shares?
👍️0
nonsequetor nonsequetor 2 years ago
Just a few more days...
👍️0
nonsequetor nonsequetor 2 years ago
CLINICAL TRIALS RESULTS JUST POSTED
https://www.clinicaltrials.gov/ct2/show/results/NCT03598088?view=results
👍️0
nonsequetor nonsequetor 2 years ago
👍️0

Your Recent History

Delayed Upgrade Clock